Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Kenvue, Starboard
Starboard Takes Stake in Consumer Products Maker Kenvue, Sources Say
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public last year, two people familiar with the matter said on Sunday. Reuters was not able to immediately learn the size of the stake.
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, and Neutrogena. These strong brand images can leverage the firm's growth and transformation of Kenvue.
Kenvue Stock Rallies After Activist Investor Takes Stake
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the Listerine maker, and wants changes made to boost the stock price. **
20h
on MSN
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)
Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist ...
21h
Starboard says Kenvue's skin health segment weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
12h
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
1d
Kenvue price target raised to $27 from $24 at BofA
BofA raised the firm’s price target on Kenvue (KVUE) to $27 from $24 and keeps a Buy rating on the shares. Noting that The Wall Street ...
1d
on MSN
Activist Starboard could push for Kenvue to sell some/all of its SHB business - analyst
Financial writer highlights activist investor Starboard Value's push for Kenvue (KVUE) to divest its challenged skin, ...
23h
on MSN
Starboard says Kenvue's skin health segment is weighing on performance
By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...
1d
Kenvue, Inc.: Strong Brand Portfolio and Strategic Initiatives Drive Buy Rating with $27 Price Target
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
devdiscourse
9h
Global Health Headlines: Major Developments in Medications and Outbreaks
Recent health news includes a court ruling allowing Amgen's Eylea biosimilar launch, Starboard criticizing Kenvue's skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Starboard
Jeff Smith
Boeing
Tesla
Tylenol
Feedback